Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Nuo Therapeutics, Inc. has filed 1,158 SEC EDGAR filings since 10 Dec 1999

SEC filing history

Showing 576-600 of 790 matching filings.

Per page
25
Current page
24
4

OWNERSHIP DOCUMENT

Filing date
10 Feb 2012
Reporting date
08 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
10 Feb 2012
Reporting date
08 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
10 Feb 2012
Reporting date
08 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
09 Feb 2012
Reporting date
08 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Jan 2012
Reporting date
17 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Jan 2012
Reporting date
17 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Jan 2012
Reporting date
17 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
09 Jan 2012
Reporting date
09 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
03 Jan 2012
Reporting date
28 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
06 Dec 2011
Reporting date
01 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Dec 2011
Reporting date
01 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Dec 2011
Reporting date
01 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

8-K filing

Filing date
25 Nov 2011
Reporting date
18 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-170747

424B3

Filing date
15 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-147793

424B3

Filing date
15 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-168936

424B3

Filing date
15 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-170747

PROSPECTUS FILED PURSUANT TO RULE 424(B)(3)

Filing date
02 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-170747

EFFECT filing

Filing date
01 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
01 Nov 2011
Reporting date
25 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
31 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-170747

POS AM filing

Filing date
26 Oct 2011
Reporting date
Not listed
Next action
Verify source filing
S-8 POS File 333-162135

S-8 POS filing

Filing date
26 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .